Isoliquiritin apioside NEW
| Price | $48 | $113 | $179 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-15 |
Product Details
| Product Name: Isoliquiritin apioside | CAS No.: 120926-46-7 |
| Purity: 99.09% | Supply Ability: 10g |
| Release date: 2026/07/15 |
Product Introduction
Bioactivity
| Name | Isoliquiritin apioside |
| Description | Isoliquiritin apioside, isolated from Glycyrrhizae radix rhizome, significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells. Isoliquiritin apioside has marked potential to combat oxidative stress-induced genotoxicity. |
| Storage | Keep away from direct sunlight, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (18.16 mM), Solution. DMSO : 33.3 mg/mL (60.49 mM), Sonication is recommended. 10% DMSO+90% Saline : < 10 mg/mL (18.16 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | p38MAPK | p38 MAPK | Nuclear factor-κB | Nuclear factor-kappaB | NF-κB | NFκB | NF-kB | NFkB | MMP | metastasis | Matrix metalloproteinases | MAPK | Isoliquiritin apioside | Inhibitor | inhibit | HT1080 | HIF-1α | cancer | angiogenesis |
| Inhibitors Related | Sodium propionate | Rhamnose monohydrate | Kojic acid | Uridine | Fumaric acid | Doxycycline | 1,4-Naphthoquinone | Glucosamine | Ethyl linoleate | D-Psicose | N,N-Dimethylacetamide | Magnesium sulfate |
| Related Compound Libraries | Polyphenolic Natural Product Library | Flavonoid Natural Product Library | Pain-Related Compound Library | Traditional Chinese Medicine Monomer Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Natural Product Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Natural Product Library for HTS | Bioactive Compounds Library Max | Ancient Chinese Classical Formulas Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:18031-40-8
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2008.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
|
Shanghai Standard Technology Co., Ltd.
|
2023-02-24 | |||
|
Shanghai Standard Technology Co., Ltd.
|
2023-02-24 | |||
| $1.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-14 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY